Background

The association between chronic air pollution exposure and respiratory health is well-established [1,2,3]. Regarding the underlying mechanisms, evidence supports that air pollutants can activate low-grade subclinical inflammatory biomarkers, which increase oxidative stress and further impair systemic respiratory health [3, 4].

Airway inflammatory biomarkers [5] reflect local inflammation in the lung and are directly associated with the development of respiratory morbidity [6,7,8,9]. There are various biomarkers representing different mechanisms of inflammatory pathways. Besides biomarkers of DNA oxidative damage and biomarkers of inflammation following oxidative damage (e.g. TNF-α), there are biomarkers of mediators following inflammation and oxidative damage e.g. LTB4 [8]. For example, alveolar macrophages ingest and clear inhaled particles and their stimulation leads to an increase of tumor necrosis factor-α (TNF-α) levels [10, 11]. LTB4 induces apoptosis in endothelial cells of the pulmonary artery, thereby affecting tissue injury and inflammation [12], and contributing significantly to neutrophil inflow into the airways of COPD patients [13]. Airway inflammatory biomarkers offer the possibility of detecting respiratory impacts at an early stage of disease development and could further be used to assess the individual progress of chronic obstructive pulmonary disease (COPD) [14, 15], where the elderly are considered particularly vulnerable.

In this regard, we have already reported an association between five-year means of air pollution exposure and increased levels of airway inflammatory biomarkers, such as TNF-α and leukotriene (LT) B4 in induced sputum from elderly individuals [16]. However, it is likely that the association between air pollution and respiratory health is influenced by individual genetic susceptibility [17,18,19]. Genetic variation in single nucleotide polymorphisms (SNPs) contributes to some variability in the individual response to air pollutants and the probability to develop respiratory impairment [20, 21]. SNPs acting along with environmental factors on respiratory health have already been reported in gene-environment interaction (GxE) studies [17, 18]. So far, to the best of our knowledge only one GxE study exists, which focused on SNPs belonging to the oxidative stress pathway [19]. However, many SNPs, each with a relatively small health effect, are linked within natural synergies across the entire genome. SNPs with genome-wide significance summarized in polygenic risk scores (PRS) can precisely estimate individual genetic susceptibility [22, 23].

This study aimed to investigate the role of polygenic susceptibility on the pathway of chronic air pollution exposure to subclinical airway inflammation in elderly women from the population-based longitudinal Study on the influence of Air pollution on Lung function, Inflammation and Aging (SALIA) cohort study. Adjusted linear GxE models with internally weighted PRS were fitted to the airway inflammatory biomarkers TNF-α, LTB4, and the total number of cells (sum of eosinophils, macrophages, neutrophils and epithelial cells) at a mean age of 74 years.

Methods

In the ongoing SALIA cohort, 4,874 women aged 55 years living between 1985 and 1994 in the Ruhr area and the adjacent Münsterland, Germany, were enrolled. Further details of the study have been described previously [5, 24]. The study has been performed in accordance with the Declaration of Helsinki and approval was obtained from Ethics Committees of the Ruhr University, Bochum (reference number: 2732), and the Heinrich Heine University, Düsseldorf (reference number: 3507). Written informed consent from all women was received. In the current study, data from baseline, the first (2006, n = 4,027), and the second follow-up examinations (2007–10, n = 834) were analysed. The study sample was restricted to 296 women with available information on air pollution, genetics, LTB4 and the total number of cells at the second follow-up examination (age of 68–79 years) (292 women for TNF-α).

The airway inflammatory biomarkers (TNF-α, LTB4, and the total number of cells) were determined in induced sputum samples from randomly selected women. Induced sputum was collected after inhalation of vaporized isomolar saline solution for 10 min and coughing provoked according to Raulf-Heimsoth et al. [25]. Further details of the sample collection have been described previously [16]. TNF-α was measured using the PeliKine™-Tool set (CLB, Amsterdam, Netherlands) in a standard range of 1.4–1000 pg/ml and LTB4 by a competitive enzyme immunoassay (Assay Design, Ann Arbor, MI, USA) with a detection limit of 11.7–3000 pg/ml. The total number of cells [× 105] was determined as the sum of eosinophils, macrophages, neutrophils and epithelial cells. Higher levels of airway inflammatory biomarkers represented greater subclinical inflammation and indicated higher risk for respiratory impairment. In our models, the airway inflammatory biomarker levels were log-transformed due to skewed distributions.

Individual exposures to nitrogen dioxide (NO2), nitrogen oxides (NOx), particulate matter with aerodynamic diameters of ≤ 2.5 μm, ≤ 10 μm, and 2.5–10 µm (PM2.5, PM10, PMcoarse), and the reflectance of PM2.5 filters (PM2.5 absorbance) were estimated from average concentrations at women’s residential addresses, derived from land-use regression models assigned within the European Study of Cohorts for Air Pollution Effects (ESCAPE). Details of measurements have been described before [26, 27] and are summarised in the Additional file 1. In our study, we used the mean of annual average concentrations from baseline and first follow-up examinations with statistical centring across the participants to model chronic air pollution exposure of 15 years prior to the biomarker assessment. Higher concentrations of air pollution represented higher exposure and were standardized in interquartile ranges (IQR).

Genome-wide genotyping using the Axiom Precision Medicine Research Array GRCh37/hg19 (Affymetrix, Santa Clara, CA, USA) and quality controls [28] were performed and genetic variants were imputed against the Haplotype Reference Consortium using the Michigan Imputation Server [29] (see Additional file 1). The selection of relevant SNPs was based on the genome-wide association study (GWAS) of lung function and COPD [21] that identified 279 genome-wide significant SNPs (Additional file 2: Table S1). The biomarker-specific PRS were defined as the weighted sum of the individual number of risk alleles of the selected SNPs and calculated using the genetic risk score-interaction-training approach as recommended by Hüls et al. [30]. The data were split into a training and a test dataset. The training dataset was used to calculate the weight of each SNP on the specific biomarker and the test dataset to calculate the weighted PRS on the specific biomarker and to perform the GxE analysis. The internal weights were gained from interaction terms between each SNP and the air pollution exposure using elastic net regression models. The interaction terms were used, since there might be SNPs that were only important in areas with high air pollution exposure and these SNPs might not be included in association analyses of the main airway inflammatory effect alone. The optimal balance of sample sizes between training and test dataset in our study was determined to be 1:2 [30]. A higher PRS represented a higher number of risk alleles and was standardized in IQRs.

Descriptive study characteristics, the airway inflammatory biomarker levels, and air pollution exposure levels are presented. Linear regression models were fitted to loge-TNF-α level, loge-LTB4 level, and the loge-total number of cells with each air pollutant separately to avoid collinearity between pollutants. Using the test dataset, firstly, environmental main effects and secondly, the polygenic main effects were estimated. Furthermore, GxE effects were evaluated via a multiplicative interaction term between the air pollutant and PRS also using the test dataset. All models were adjusted for potential confounders selected a priori [19] including age, body mass index (BMI in kg/m2), highest education of the women or her spouse (low < 10 years, medium = 10 years, high > 10 years of education), ever-/never-smoking and second-hand smoking. Possible confounding due to residential moving could be neglected because only 1.7 percent (5 of 296) of the women changed their residential address in the last five years before the airway biomarker assessment. Results are presented in percentage changes of TNF-α level, LTB4 level, and the total number of cells and beta coefficients of loge-airway inflammatory biomarkers, as well as the corresponding 95% confidence intervals (CI) and p-values. P-values < 0.05 (two-sided) were considered as statistically significant and p-values < 0.1 were marked in the results. R version 4.1.2 [31] was used for all statistical analyses. In sensitivity analyses, first, we tested the role of binary polygenic risk (high-risk vs. low-risk group) where the group assignment was conducted according to the median of continuous polygenic risk score. Furthermore, we added indoor air pollution (exposure to mould) and heating with fossil fuels as additional potentially confounders [16]. Additionally, we investigated the main and GxE effects without adjustment for BMI as it could act more as a mediator than a confounder. We performed stratified GxE analyses to investigate potential effect modification according to chronic inflammatory respiratory conditions, such as asthma, chronic bronchitis, hay fever, cough, cough with sputum or COPD [16]. Finally, we tested another PRS including only the sentinel SNPs belonging to causal genes presented in Shrine et al. [21].

Results

The 296 women included were on average 74.4 years old and of overweight. About a half of the participants had an education level of 10 years. Of the women, 16.6% were ever smokers and 58.5% had been exposed to second hand smoke (Table 1). The geometric means (geometric standard deviations) were 1.8 (2.1) pg/ml for TNF-α, 646.3 (2.1) pg/ml for LTB4, and 14.8 (2.7) × 105 for the total number of cells. The median chronic air pollution exposure was lower than the annual limits of the European Union (RL 2008/50/EG) for PM10 (40 µg/m3), and NO2 (40 µg/m3), and about the same for PM2.5 (25 µg/m3) [32]. However, with regard to the annual air quality guideline levels recommended in 2021 by the World Health Organization (NO2: 10 µg/m3; PM2.5: 5 µg/m3; PM10: 15 µg/m3) [33], the median exposures were higher than recommended. The descriptive results of the SALIA study samples and the sample with air pollution and genetic assessment available, but without airway inflammatory biomarkers available indicated selection bias should be minimal (Additional file 2: Table S2).

Table 1 Description of the study characteristics and air pollution exposures

NO2 = nitrogen dioxide, NOx = nitrogen oxides, PM2.5/10/coarse = particulate matter with aerodynamic diameters ≤ 2.5/ ≤ 10/ 2.5–10 µm, PM2.5 absorbance = reflectance of PM2.5 filtersThe environmental main effects are presented in Fig. 1 and together with the polygenic main effects in Additional file 2: Table S3. One IQR-increase in the exposure to NO2, NOx, PM2.5, PM10, and PMcoarse was significantly associated with an increase in LTB4 levels of 19.7% (p = 0.005), 20.9% (p = 0.002), 22.1% (p = 0.004), 17.4% (p = 0.004), and 23.3% (p = 0.001), respectively. Furthermore, we found significant effects of NO2 (25.9%, p = 0.008) and NOx (25.9%, p = 0.004) on the total number of cells. One significant polygenic main effect was found for TNF-α using polygenic weights from the interaction terms between each SNP and NOx.

Fig. 1
figure 1

Environmental main effects of chronic air pollution exposure on airway inflammatory biomarker levels. % change percentage change in biomarker level, CI confidence interval, * = p-value: < 0.01, tumor necrosis factor-α (TNF-α), leukotriene (LT) B4, total number of cells = the sum of eosinophils, macrophages, neutrophils and epithelial cells, NO2 = nitrogen dioxide, NOx = nitrogen oxides, PM2.5/10/coarse = particulate matter with aerodynamic diameters ≤ 2.5/ ≤ 10/ 2.5–10 µm, PMabs = PM2.5 absorbance, reflectance of PM2.5 filters Air pollutants: The mean of the annual average concentrations from baseline and first follow-up examination within a time window of 15 years prior to the airway inflammatory biomarker assessments, standardized using interquartile ranges. Adjusted for: age, body mass index (BMI in kg/m2), highest education of the participant or spouse, ever-/never-smoking and second-hand smoking

All environmental main effects remained stable in the main GxE model. However, we did not find a significant GxE effect (Fig. 2, Additional file 2: Table S5).

Fig. 2
figure 2

Effects of air pollutant exposure on airway inflammatory biomarkers for each IQR-increase of the PRS. loge-tumor necrosis factor-α (TNF-α), loge-leukotriene (LT) B4, loge-total number of cells = the sum of eosinophils, macrophages, neutrophils and epithelial cells, NO2 = nitrogen dioxide, NOx = nitrogen oxides, PM2.5/10/coarse = particulate matter with aerodynamic diameters ≤ 2.5/ ≤ 10/ 2.5–10 µm, PM2.5 absorbance = reflectance of PM2.5 filters, IQR interquartile range, PRS polygenic risk score, dashed line indicates beta estimate = 0. Individual weighted polygenic risk scores (normally distributed) derived by the interaction-training approach, standardized using interquartile ranges. Air pollutants: the mean of the annual average concentrations from baseline and first follow-up examinations within a time window of 15 years prior to the airway inflammatory biomarker assessments, statistically centred across the participants, standardized using interquartile ranges. Adjusted for: age, body mass index (BMI in kg/m2), highest education of the participant or her spouse, ever-/never-smoking and second-hand smoking

In the sensitivity analyses with binary PRS (Additional file 2: Table S6), no adjustment for BMI (Additional file 2: Tables S4 and S8), and additional adjustment according to indoor air pollution (exposure to mould) and heating with fossil fuels (Additional file 2: Table S7), the trends remained stable. Excluding women with any chronic inflammatory respiratory condition did not change the GxE effects (Additional file 2: Table S9). However, this exclusion decreased the air pollution effects on LTB4 and increased the effects on TNF-α of NOx from a 6.2 to 15.0% increase (p = 0.278 vs. 0.041) and PM2.5 absorbance from a 1.0 to 16.2% increase (p = 0.884 vs. 0.037). Testing the PRS with only the sentinel SNPs belonging to causal genes included, showed consistent results and additional GxE indications for PM2.5 on TNF-α and PM2.5 absorbance on TNF-α and the total number of cells.

Discussion

In this study, the role of polygenic susceptibility on the pathway of chronic air pollution exposure to subclinical airway inflammation in elderly women was investigated focusing on three biomarkers TNF-α, LTB4, and the total number of cells in sputum. In adjusted linear regression models, we found significant environmental main effects between chronic exposures to NO2, NOx, PM2.5, PM10, and PMcoarse and an increase in LTB4 level. Furthermore, the total number of cells was significantly increased by chronic exposures to NO2 and NOx. No significant interaction effects were observed. These trends were robust in sensitivity analyses testing the dichotomized PRS, the PRS with only the sentinel SNPs belonging to causal genes included, excluding adjustment for BMI, adding potential confounders (exposure to mould and heating with fossil fuels), and the modifying effect of chronic inflammatory respiratory conditions. However, for women without any chronic inflammatory respiratory condition, a harmful environmental effect on LTB4 level was not confirmed.

Our results confirm that higher chronic exposures to air pollution increase the risk of subclinical airway inflammation, hence supporting the hypothesis that subclinical inflammation is an underlying mechanism of air pollution causing respiratory impairment [3, 4]. It is known that inflammation is the first response to infections, toxins and pollutants, measurable in an increase of airway inflammatory biomarker levels. However, persistent exposure to air pollutants precludes resolution of inflammation, resulting in chronically elevated levels of biomarkers of inflammation which likely cause respiratory impairment [8]. We investigated air pollution concentrations within 15 years prior to the biomarker assessment to characterise this persistent exposure. To our knowledge [8, 16], this is the first study investigating air pollution effects on airway inflammatory biomarkers in the elderly with such a long exposure window.

In regards to the environmental main effects, the high risk of NO2 on airway inflammatory biomarkers was also found in a study on 242 elderly COPD patients (mean age of 67.8 years) in which ESCAPE-derived exposures to PM2.5 and NO2 were examined on C-reactive protein, TNF-α, interleukin (IL)-6, IL-8, and hepatocyte growth factor. As in our study (both main analysis and analysis on women without any chronic inflammatory conditions), the association between NO2 and TNF-α level did not reach statistical significance, but showed a harmful trend [34]. Furthermore, there was evidence for healthy individuals as well as individuals with chronic diseases, such as asthma, COPD, and chronic bronchitis, that a doctor visit due to respiratory symptoms was associated with exposure to NO2 [34, 35]. While most of these study individuals were male [34, 35], our study added findings for elderly women of the harmful effects of chronic NOx and NO2 on LTB4 level and the total number of cells, respectively.

Very limited studies have investigated the association between air pollution exposure and LTB4 level, although the role of LTB4 on respiratory health is well known [8, 19]. Our study helps to clarify the evidence and supports the importance of LTB4 through showing significant harmful effects of exposure to NO2, NOx, PM2.5, PM10, and PMcoarse. The decreasing trend of air pollution effects on LTB4 level in women without any chronic inflammatory respiratory condition could indicate the importance for elderly women with COPD. However, the results must be taken with caution because of the small sample sizes.

Additionally, there are some studies of the association between genetics and airway inflammatory biomarkers. In the family-based Framingham Heart Study, heritability and candidate gene associations of inflammatory biomarkers (overlap with the biomarkers included here: TNF-α) were investigated, but no correlations with TNF-α were found [36]. Moreover, in a GWAS of systemic inflammatory biomarkers of subjects with COPD [37] and a meta-analysis of current and former smokers with or without COPD [38], none of the SNPs was associated with TNF-α level (overlap: TNF-α). In a meta-analysis of 34 studies involving 5,477 asthma patients and 5,962 controls TNF-α rs1800629 (no overlap) polymorphism was only significantly associated with asthma risk in Asian populations, but not in Caucasian populations [39]. In another meta-analysis, TNF-α -308 G/A polymorphisms (no overlap) was also associated only among Asian populations with an increased risk for COPD, but not in non-Asian individuals [40]. There are fewer studies considering genetic effects on LTB4 and the total number of cells. Regarding LTB4, no significant association was found with LTA4H regulatory variant rs2660845 (no overlap) in European late-onset asthma individuals [41]. Our study is consistent with these results by showing no stable significant polygenic effects, although these studies are only comparable with our study to a limited extent due to the different genetic approaches and the rarely examined elderly population.

The association between chronic air pollution and respiratory health on airway inflammation is likely to be influenced by individual genetic susceptibility [17, 18, 20]. To the best of our knowledge, there is only one GxE study of air pollution-induced airway inflammation. This study focused on SNPs relevant to the oxidative stress pathway [19], making it the first study considering SNPs in natural synergies across the entire genome, summarized in PRS [22, 23]. While Hüls et al. [19] found the strongest GxE for LTB4, we found no GxE effects. Possible explanations are, on one hand, that the GWAS of lung function and COPD [21] used in our study did not cover the relevant SNPs for subclinical airway inflammation [42], and especially not those SNPs that interacted with air pollution. SNPs that were only important in areas with low air pollution might not have reached genome-wide significance in the GWAS, but would be identified in genome-wide association interaction studies and genome-wide by environmental interaction studies [43].

On the other hand, GxE effects could have a different starting point within the pathway. With our approach, we examined GxE effects on subclinical airway inflammation, where the GxE effect could also influence systemic inflammation instead of subclinical inflammation. Maybe the subclinical inflammation induced by air pollution was not dependent on polygenic susceptibility, but the polygenic susceptibility affected the development of subclinical inflammation towards either respiratory impairment or recovery. Hüls et al. [44] have already shown that an air pollution-associated improvement of lung function depends on the individual genetic risk, which might be associated with subclinical airway inflammation. This would support our hypothesis. However, further studies examining the whole pathway are necessary to confirm this. Our findings are generalizable to other healthy elderly Caucasian women. With regard to the different genetic effects between Asian and Caucasian populations in other studies, it is likely that polygenic susceptibility as well as the GxE effects differ between ancestry groups.

Strengths of our study are the population-based design, standardized procedures to measure the biomarkers, and standardized and comparable ESCAPE air pollution data covering a time window of 15 years prior to the biomarker assessments. Several sensitivity analyses were performed to confirm our findings, rule out selection bias, and investigate modifying effects by chronic inflammatory respiratory conditions.

However, there were also some limitations. In the SALIA cohort, the effect of air pollution and the GxE effect could be underestimated due to the loss to follow-up examination of women with less education, higher air pollution exposure and worse respiratory health [19]. In our study, TNF-α results must be treated with caution because about 40% of the measurements were below the detection limit [19]. Due to the lack of genome-wide interaction studies and GWAS on specific airway inflammation biomarkers, the polygenic susceptibility to subclinical airway inflammation was based on SNP selection regarding general lung function and COPD, which might result in different SNPs and could consequently affect polygenic main or GxE effects. Using external weights would improve the external validity of GxE results. In addition, a lack of statistical power due to the small sample sizes could be a reason for not identifying interaction effects.

Conclusions

While this study confirmed that higher chronic exposure to air pollution increased the risk of subclinical airway inflammation in elderly women, we could not detect a significant role of polygenic susceptibility on this pathway. Our study added to the evidence on airway inflammation in elderly women, especially for the harmful effects of NO2 and NOx on subclinical inflammation, considering a 15-year long exposure window, and the harmful air pollution effects on LTB4 levels. Further GxE studies including genome-wide derived SNPs are required to investigate the role of polygenic susceptibility to air pollution-induced subclinical airway inflammation and to provide further insights into underlying mechanisms.

Take home message

Higher chronic exposure to air pollution increases the risk of subclinical airway inflammation in elderly women. Our study could not detect a significant role of polygenic susceptibility in air pollution-induced subclinical airway inflammation and further studies are required.